OPPENHEIMER & CO INC

Position in ELAN — Elanco Animal Health Inc

CIK 822581 NEW YORK, NY

Position in ELAN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$220,825

+$6,102 QoQ

Shares Held

8,973

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#368

of 515 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OPPENHEIMER & CO INC holds $19,819,101 across 9 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	116,275	$8,355,521
2	NBIX	Neurocrine Biosciences Inc	47,800	$8,056,212
3	UTHR	UNITED THERAPEUTICS Corp	3,090	$1,674,254
4	VTRS	Viatris Inc	29,649	$470,826
5	TEVA	Teva Pharmaceutical Industries Ltd	9,574	$324,367
6	LNTH	Lantheus Holdings, Inc.	2,757	$305,861
7	ELAN	Elanco Animal Health Inc This page	8,973	$220,825
8	AQST	Aquestive Therapeutics, Inc.	51,052	$212,376

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,825	8,973	0.0%	Shares	Sole	2026-08-03
2026-03-31	$214,723	8,973	-21.3%	Shares	Sole	2026-04-24
2023-06-30	$114,663	11,398	-21.1%	Shares	Sole	2023-08-03
2023-03-31	$135,858	14,453	-11.5%	Shares	Sole	2023-05-10
2022-12-31	$199,528	16,328	-10.9%	Shares	Sole	2023-02-08
2022-09-30	$227,313	18,317	-18.0%	Shares	Sole	2022-11-14
2022-06-30	$438,455	22,336	-15.8%	Shares	Sole	2022-08-08
2022-03-31	$692,402	26,539	-0.2%	Shares	Sole	2022-05-12
2021-12-31	$754,595	26,589	+50.6%	Shares	Sole	2022-02-02
2021-09-30	$563,017	17,655	0.0%	Shares	Sole	2021-11-12
2021-06-30	$612,451	17,655	+6.5%	Shares	Sole	2021-08-03
2021-03-31	$488,133	16,575	-3.2%	Shares	Sole	2021-05-10
2020-12-31	$524,917	17,115	-28.4%	Shares	Sole	2021-02-11
2020-09-30	$667,247	23,890	-9.7%	Shares	Sole	2020-11-13
2020-06-30	$567,609	26,462	—	Shares	Sole	2020-08-11
No filing history on record for this holder in this stock.